Chief of Technology Development and Vice President Research @ KAI Pharmaceuticals
Chief of Technology Development and Vice President Molecular and Integrative Pharmacology @ KAI Pharmaceuticals
Senior Vice President of Research and Preclinical Development @ Cellgate
Vice President of Preclinical Research and Pharm and Tox and Director of CNS Programs @ DURECT Corporation
Dept Head Neurobiology and Mol and Cell Biochem, Ctr for Biological Res, Roche Bioscience @ Roche
Randolph Johnson's Education
University of South Carolina School of Medicine
Ph.D. (Biomedical Sciences-Pharmacology)
1979 - 1984
California State University, Long Beach
M.A. (Biology-Physiology)
1975 - 1978
California State University, Long Beach
B.S. (Zoology)
1970 - 1974
University of Virginia School of Medicine, Department of Pharmacology
Postdoctoral Research Fellowship (Molecular Pharmacology)
1984 - 1987
Randolph Johnson's Skills
Drug Delivery
Clinical Development
R&d
Clinical Trials
Executive Management
Regulatory Affairs
Clinical Research
Intellectual Property
Medical Devices
Drug Development
Randolph Johnson's Summary
Randolph Johnson, based in Half Moon Bay, California, United States, is currently a Chief Scientific Officer at Angarus Therapeutics, bringing experience from previous roles at Tolerion, Inc., Statim Pharmaceuticals, RMJ Biomedical Advisors and Amgen. Randolph Johnson holds a 1979 - 1984 Ph.D. in Biomedical Sciences-Pharmacology @ University of South Carolina School of Medicine. With a robust skill set that includes Drug Delivery, Clinical Development, R&d, Clinical Trials, Executive Management and more, Randolph Johnson contributes valuable insights to the industry. Randolph Johnson has 2 emails on RocketReach.